CD14 and cancer: To delineate antibody-mediated anti-cancer immune reactions by flow cytometry, samples were stained with the epithelial cancer cell marker EpCAM to identify cancer cells (Figure S2C) together with immune lineage markers CD14, CD3, CD56 to differentiate effects on cancer cells, monocytes, T and NK cells, respectively (Figure 3B).